Contact Us

Reminyl
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Reminyl

Pharmacies Ignore Pullout Order, Sell Harmful Ophthalmic Solution

Jun 26, 2006
| www.arabnews.com
Despite the announcement a month ago by the manufacturers of a highly harmful ophthalmic solution that they were recalling the product, the item is...

Reminyl (galantamine) Precautions due to Deaths Reported in Clinical Trials

Apr 1, 2005
| www.pharmalive.com
Ortho-McNeil Neurologics modified the PRECAUTIONS section of the Prescribing Information for Reminyl, approved only for the treatment of mild to...

Trials Show Higher Death Rate Among Some Test Subjects Using Reminyl

Jan 22, 2005
| AP
Patients taking Alzheimer's drug Reminyl in a test for another use had higher death rates than those taking a placebo, Johnson & Johnson...

Page 1/1